ENTITY

PharmaResearch (214450 KS)

19
Analysis
Health Care • South Korea
PharmaResearch Co., Ltd. operates as a marine biopharmaceuticals company. The Company manufactures and sells botulinum toxin formulations and other products. PharmaResearch also produces and sells medical equipment and cosmetics.
more
bearish•Quantitative Analysis
•06 Oct 2025 07:05

KRX Foreign Holding Weekly (Oct 3rd): SK Hynix, Samsung Electronics, Samsung Elec (PREF), NAVER

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SK Hynix, Samsung Electronics, Samsung Elec...

Logo
320 Views
Share
•02 Oct 2025 07:01•Broker

Equity Strategy[October] Reduced Earnings Volatility Is the Key to a Re-Rating

The 3Q25 earnings season is set to kick off following the Chuseok holiday. The consensus for Korean companies’ aggregate operating profit stands at...

Logo
246 Views
Share
bullish•Quantitative Analysis
•29 Sep 2025 07:05

KRX Foreign Holding Weekly (Sep 26th): Samsung Electronics, SK Hynix, NAVER, Doosan Enerbility

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, NAVER, Doosan...

Logo
325 Views
Share
bullish•Genic Co Ltd
•21 Sep 2025 15:57

Korea Small Cap Gem #45: Genic

Genic is a turnaround story. Genic is one of the largest ODM companies that make beauty face masks in Korea. Genic is one of the biggest suppliers...

Logo
427 Views
Share
bullish•Peptron
•09 Sep 2025 14:12

A Flow Play on the Market-Missed Reshuffle in KRX Bio Top 10

This post highlights a flow play on the market-overlooked KRX Bio Top 10 reshuffle, outlining key adds/deletes, expected passive flows, and timing...

Logo
358 Views
Share
x